IMR90 ER:RAS: A Cell Model of Oncogene-Induced Senescence
Authors:
- 25 November 2018
- book chapter
- Published by Springer Nature
- Vol. 1896, 83-92
Abstract
Oncogene-induced senescence (OIS) is a cellular response that limits the replication of cells expressing oncogenes. As a result, OIS is a potent tumor suppressor mechanism limiting cancer progression. Here we describe IMR90 ER:RAS, a widely used model to study OIS in cell culture. This model takes advantage of IMR90 human primary fibroblast infected with a 4-hydroxy-tamoxifen (4-OHT) inducible ER:RAS construct. RAS activation upon 4-OHT treatment results in a coordinated induction of senescence, recapitulating different aspects of the phenotype such as the growth arrest and the establishment of a senescence-associated secretory phenotype (SASP).Keywords
This publication has 20 references indexed in Scilit:
- Senescence surveillance of pre-malignant hepatocytes limits liver cancer developmentNature, 2011
- The essence of senescence: Figure 1.Genes & Development, 2010
- Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RASGenes & Development, 2009
- Senescence-messaging secretome: SMS-ing cellular stressNature Reviews Cancer, 2009
- Senescence of Activated Stellate Cells Limits Liver FibrosisCell, 2008
- Breaking news: high-speed race ends in arrest – how oncogenes induce senescenceTrends in Cell Biology, 2007
- BRAFE600-associated senescence-like cell cycle arrest of human naeviNature, 2005
- Senescence in premalignant tumoursNature, 2005
- Epidermal Ras blockade demonstrates spatially localized Ras promotion of proliferation and inhibition of differentiationOncogene, 2002
- The Hallmarks of CancerCell, 2000